¼¼°èÀÇ °æÇÇ ÆÐÄ¡ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, ¿¹Ãø : À¯Çü, À¯Åë ä³Î, ¿ëµµ, Áö¿ªº°(2025-2033³â)
Transdermal Skin Patches Market Size, Share, Trends and Forecast by Type, Distribution Channel, Application, and Region, 2025-2033
»óǰÄÚµå : 1722864
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 147 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,130,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,507,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 6,884,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°æÇÇ ÆÐÄ¡ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â 82¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö ÀÌ ½ÃÀåÀÌ 2025-2033³â 3.69%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³»°í, 115¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ÇöÀç ºÏ¹Ì°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, 2024³â¿¡´Â 35.5%ÀÇ ³ôÀº ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀÌ ¼ºÀåÇϰí ÀÖ´Â ÀÌÀ¯´Â Çõ½ÅÀûÀÎ °æÇÇÀû ±â¼úÀ» µÞ¹ÞħÇϴ ÷´Ü ÀÇ·á ÀÎÇÁ¶ó°¡ Àֱ⠶§¹®ÀÔ´Ï´Ù. ¸¸¼ºÁúȯÀÇ ³ôÀº À¯º´·ü·Î ÀÎÇØ È¿°úÀûÀÌ°í ºñħ½ÀÀûÀÎ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦¾àȸ»çÀÇ °­·ÂÇÑ ÀÔÁö¿Í À¯¸®ÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©´Â Á¦Ç° °³¹ß ¹× ±ÔÁ¦ ½ÂÀÎÀ» ÃËÁøÇÏ¿© °æÇÇ ÆÐÄ¡ ¼¼°è ½ÃÀå Á¡À¯À²¿¡¼­ ÀÌ Áö¿ªÀÇ Á߿伺À» È®°íÈ÷ Çϰí ÀÖ½À´Ï´Ù.

°æÇÇ ÆÐÄ¡´Â ºñħ½ÀÀûÀÌ°í »ç¿ëÇϱ⠽¬¿î ¾à¹° Àü´Þ ¹æ½ÄÀ¸·Î, ÀÏÁ¤·®ÀÇ Ä¡·áÁ¦¸¦ ¹Ì¸® Á¤ÇØÁø ½Ã°£ µ¿¾È Ç÷·ù¿¡ Åõ¿©ÇÏ´Â °ÍÀ» ¸»ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¾à¹°Àº ¹éÅ·, ¾à¹°, ¸âºê·¹ÀÎ, Á¢ÂøÁ¦, ¶óÀ̳Ê, È­ÇÐÀû °­È­Á¦ ¶Ç´Â ħÅõÁ¦, ¹°¸®Àû º¸Á¶Á¦, À̿¿µµ¿°ú °°Àº ¾àÇÑ Àü·ù·Î ±¸¼ºµË´Ï´Ù. À̵éÀº ÇǺÎÀÇ Æ¯¼º°ú ÆÐÄ¡ µðÀÚÀο¡ µû¶ó ÀÏÁ¤ÇÑ È®»ê ¼Óµµ¸¦ Á¦°øÇÕ´Ï´Ù. ÇöÀç È­Àåǰ, ¿Ü¿ëÁ¦, °æÇÇÈí¼öÇü Á¦Á¦·Î Àü ¼¼°èÀûÀ¸·Î ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù.

°æÇÇ ÆÐÄ¡ ½ÃÀå µ¿Çâ :

°æÇÇ ÆÐÄ¡´Â ½ÉÀ庴, È£¸£¸ó Àå¾Ö, ÆíµÎÅë, ÆÄŲ½¼º´, ¾ËÃ÷ÇÏÀ̸Ӻ´, ³úÁ¹Áß, Àΰ£¸é¿ª°áÇ̹ÙÀÌ·¯½º(HIV), °ñ´Ù°øÁõ, ÇÏÁöºÒ¾ÈÁõÈıº µîÀÇ Ä¡·á¿¡ È¿°úÀûÀÔ´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ Áúº´À» ¾Î°í ÀÖ´Â Àα¸ÀÇ ºñÀ²ÀÌ Å©°Ô Áõ°¡Çϰí ÀÖ´Â °ÍÀº ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â Áß¿äÇÑ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ ÆÐÄ¡´Â ÀǾàǰÀ» ¼·ÃëÇÏ´Â ÀüÅëÀûÀÎ °æ±¸ °æ·Î¸¦ ÇÇÇϰí Á¤¸Æ ¶Ç´Â ºñ°æ±¸ ¿ä¹ýÀ¸·Î ÀÎÇÑ ºÒÆíÀ» ÁÙÀ̰í À§Àå µ¶¼º, ¸Þ½º²¨¿ò ¹× ±¸Å並 ¿¹¹æÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ, Åõ¿©°¡ ¿ëÀÌÇϱ⠶§¹®¿¡ ¸¸¼º ÅëÁõ ¹× ±Ý¿¬ Ä¡·á¸¦ À§ÇÑ Àå±â Ä¡·á Áß È¯ÀÚÀÇ ¼øÀÀµµ¸¦ Çâ»ó½Ã۱â À§ÇØ °æÇÇ ÆÐÄ¡ÀÇ ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, Àú·ÅÇÑ ºñ¿ëÀ¸·Î ´õ ³ªÀº Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ´Ù¾çÇÑ ¾à¹° °è¿­¿¡ ´ëÇÑ ÀÓ»ó½ÃÇèÀÇ ¼ö°¡ Å©°Ô Áõ°¡Çϸ鼭 ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾Ð·Â¿¡ ¹Î°¨ÇÑ Á¢ÂøÁ¦ ¹× ħÅõ ÃËÁøÁ¦ÀÇ µµÀÔÀº Á¦Ç°ÀÇ È®»êÀ» ÃËÁøÇÏ°í ¾à¹° º¸À¯ ´É·ÂÀ» °­È­ÇÏ¿© ½ÃÀå ±â¾÷¿¡°Ô À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇϰí ÇâÈÄ ¸î ³â µ¿¾È Àü ¼¼°èÀûÀ¸·Î °æÇÇ ÆÐÄ¡ÀÇ Àû¿ëÀÌ È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ °æÇÇ ÆÐÄ¡ ½ÃÀå

Á¦6Àå ½ÃÀå ºÐ¼® : À¯Çüº°

Á¦7Àå ½ÃÀå ºÐ¼® : À¯Åë ä³Îº°

Á¦8Àå ½ÃÀå ºÐ¼® : ¿ëµµº°

Á¦9Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦10Àå SWOT ºÐ¼®

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå PorterÀÇ Five Forces ºÐ¼®

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï ±¸µµ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global transdermal skin patches market size was valued at USD 8.21 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 11.56 Billion by 2033, exhibiting a CAGR of 3.69% during 2025-2033. North America currently dominates the market, holding a significant market share of 35.5% in 2024. The market is experiencing growth because of advanced healthcare infrastructure supporting innovative transdermal technologies. High prevalence of chronic conditions ensures sustained demand for effective, non-invasive treatment options. Besides this, strong presence of pharmaceutical companies and favorable regulatory frameworks drive product development and regulatory approvals, solidifying the region's significance in the global transdermal skin patches market share.

Transdermal skin patches refer to a non-invasive and easy to use drug delivery method of administering constant and consistent therapeutic dosages into the bloodstream over a predetermined time. They consist of backings, drugs, membranes, adhesives, liners, chemical enhancers and permeators, physical aids, and low electrical current like iontophoresis. They provide a consistent diffusion rate, depending on the characteristics of the skin and the design of the patch. They are nowadays widely used as cosmetic, topical, and transdermal delivery systems around the world.

Transdermal Skin Patches Market Trends:

Transdermal skin patches are effective for treating cardiac and hormonal disorders, migraine, Parkinson's disease, Alzheimer's, stroke, human immunodeficiency virus (HIV), osteoporosis, and restless leg syndrome. Thus, a significant increase in the percentage of the population suffering from these ailments represents one of the key factors impelling the market growth. Moreover, these patches help avoid the traditional oral route for ingesting medicines, lower the inconvenience caused due to intravenous or parenteral therapies, and prevent gastrointestinal toxicity, nausea, and vomiting. Furthermore, due to the ease of administration, transdermal skin patches are gaining traction to improve the compliance of the patient during prolonged treatments for chronic pains and in smoking cessation therapy. Apart from this, the escalating demand for better therapeutics at affordable costs, coupled with a significant rise in the number of clinical trials of different drugs classes, is positively influencing the market. Furthermore, the introduction of pressure-sensitive adhesives and permeation enhancers, which lead to increased product diffusion and enhanced drug retention ability, is anticipated to provide lucrative opportunities to market players and expand the application of transdermal skin patches across the globe in the coming years.

Key Market Segmentation:

Breakup by Type:

Breakup by Distribution Channel:

Breakup by Application:

Breakup by Region:

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, AdhexPharma, LTS Lohmann Therapie-Systeme AG, Luye Pharma Group, Medherant Limited, Nitto Denko Corporation, Noven Pharmaceuticals Inc. (Hisamitsu Pharmaceutical Co. Inc.), Prosolus Inc., Samyang Holdings Corporation, Tapemark, Teikoku Pharma USA Inc. (Teikoku Seiyaku Co. Ltd), tesa SE (Beiersdorf AG) and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Transdermal Skin Patches Market

6 Market Breakup by Type

7 Market Breakup by Distribution Channel

8 Market Breakup by Application

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â